Abstract:Circular RNAs (circRNAs) represent a recently described category of novel, single stranded ribonucleic acid (ssRNA) abundantly represented in the eukaryotic transcriptome. Non‐polyadenylated and intrinsically resistant to exonucleolytic attack, circRNAs are a highly stable ssRNA species significantly enriched in human brain and retinal tissues. The biological evolution and function of most central nervous system (CNS) circRNAs, however, remains poorly understood. Established methods of ssRNA detection and quantitation that require a free 3′ or 5′ ribonucleotide end may have significantly underestimated circRNA abundance and importance in CNS function in both health and disease. One highly represented circRNA in the human brain and retina is a ~1400 nucleotide (nt) ciRS‐7 that contains about ~70 tandem anti‐miRNA‐7 sequences; ciRS‐7 thereby acts as a kind of endogenous, competing, anti‐complementary miRNA inhibitor or “sponge” to adsorb, and hence quench, the normal function(s) of miRNA‐7 (hsa‐miRNA‐7‐1; 23 nt; chr 9q21.32). Using DNA and miRNA arrays, RNA‐sequencing, enhanced LED‐Northern, ELISA and Western blot hybridization, the circularity‐sensitive probe RNaseR, energy of association ( E A ) indexing and miRNA‐mRNA bioinformatics algorithms, we here provide initial evidence of a mis‐regulated miRNA‐7‐anti‐miRNA‐7‐circRNA system in sporadic Alzheimer's disease (AD) brain. Deficits in ciRS‐7, and ciRS‐7 “sponging activities” might be expected to increase ambient miRNA‐7 levels in AD‐affected tissues, as is observed, and these ultimately contribute to the down‐regulation of selective miRNA‐7‐sensitive messenger RNA (mRNA) targets. We report here that the up‐regulation of ambient miRNA‐7 in AD brain, due to a deficiency in ciRS‐7 and ciRS‐7‐mediated “sponging” effects, in turn down‐regulates several AD‐relevant mRNA targets and their expression, including the ubiquitin conjugase protein (UBE2A; miRNA‐7‐UBE2A mRNA 3′UTR E A = −22.9 kcal/mol) and the epidermal growth factor receptor (EGFR; miRNA‐7‐EGFR mRNA 3′UTR E A = −23.2 kcal/mol). UBE2A (chr Xq24; ~17kDa), a central effector in the ubiquitination cycle that helps to orchestrate the clearance of amyloid peptides via phagocytosis, is depleted in sporadic AD brain and retina and contributes to amyloidogenesis. Similarly, decreased levels of the transmembrane glycoprotein EGFR (chr 7p11.1; ~134kDa) found in AD appears to be linked to deficits in brain cell proliferation, cytoskeletal rearrangement and angiogenesis. Our conceptual understanding of the highly specialized functions for non‐coding ssRNA such as circRNAs in the human CNS continues to evolve and their presence and activities underscore the increasing complexity of miRNA‐mRNA‐mediated genetic regulatory networks. Support or Funding Information Research on miRNA signaling in the Lukiw laboratory involving the innate‐immune response in AD, AMD and in other forms of neurological or retinal disease, amyloidogenesis, ubiquitination, synaptogenesis and brain inflammation was supported through an unrestricted grant to the LSU Eye Center from Research to Prevent Blindness (RPB); the Louisiana Biotechnology Research Network (LBRN) and NIH grants NEI EY006311 and NIA AG038834 (WJL).

Upregulation of Micro RNA (mirna) Signaling in Alzheimer's Disease (AD) and Related Neurological Disorders

Down‐regulated Expression of Microrna‐338‐5p Contributes to Neuropathology in Alzheimer's Disease

MicroRNA-139 Modulates Alzheimer's-associated Pathogenesis in SAMP8 Mice by Targeting Cannabinoid Receptor Type 2.

Alterations in Micro RNA-Messenger RNA (Mirna-Mrna) Coupled Signaling Networks in Sporadic Alzheimer's Disease (AD) Hippocampal CA1

MicroRNA (mirna) Signaling in the Human CNS in Sporadic Alzheimer's Disease (Ad)-Novel and Unique Pathological Features.

O2-03-06: Micro RNA-146A–mediated Signaling in Alzheimer's Disease

MicroRNA Complexity in Alzheimer's Disease Cerebrospinal Fluid, Extracellular Fluid and Brain Tissue Biopsy

Microrna (mirna) Speciation in Alzheimer's Disease (AD) Cerebrospinal Fluid (CSF) and Extracellular Fluid (ECF).

Genome-wide Analysis of Mirna Signature in the APPswe/PS1ΔE9 Mouse Model of Alzheimer's Disease.

An Nf-Kb-Regulated Micro-Rna-146a-Mediated Inflammatory Circuit In Alzheimer'S Disease Brain

Microrna-34A (Mirna-34A) Mediated Down-Regulation of the Post-synaptic Cytoskeletal Element SHANK3 in Sporadic Alzheimer's Disease (AD)

Sponging of mirna-146a using aav-anti-mirna-146a-vectors mediates synaptic and amyloidogenic neuropathology and cognitive deficits in a 5xfad murine model of alzheimer’s disease

An NF-κB-sensitive Micro RNA-146a-mediated Inflammatory Circuit in Alzheimer Disease and in Stressed Human Brain Cells

Mirna-155 Upregulation and Complement Factor H Deficits in Down’s Syndrome

Regulation of Neurotropic Signaling by the Inducible, NF-kB-sensitive Mirna-125B in Alzheimer's Disease (AD) and in Primary Human Neuronal-Glial (HNG) Cells.

Downregulation of hsa-miR-132 and hsa-miR-129: non-coding RNA molecular signatures of Alzheimer's disease

Human microRNA (miR-20b-5p) modulates Alzheimer’s disease pathways and neuronal function, and a specific polymorphism close to the MIR20B gene influences Alzheimer’s biomarkers

MicroRNAs in Alzheimer’s Disease: Diagnostic Markers or Therapeutic Agents?

Spreading of Alzheimer'S Disease Inflammatory Signaling Through Soluble Micro-Rna

A Circular Rna (circrna) Cirs-7 in Alzheimer'S Disease (ad) Targets Mirna-7 Trafficking and Promotes Deficits in the Expression of the Ubiquitin Conjugase (ube2a) and the Epidermal Growth Factor Receptor (Egfr)

Anti-microRNAs as Novel Therapeutic Agents in the Clinical Management of Alzheimer's Disease.